Novo Nordisk has launched its once-weekly insulin injection, Awiqli, in India for adults with diabetes. Priced at Rs 261 per week, the company aims to help more diabetics switch to this convenient treatment option.

India has launched the world's first once-a-week insulin, Novo Nordisk's Awiqli, offering a new treatment option for diabetes patients.

Novo Nordisk has secured US FDA approval for its once-weekly insulin Awiqli, expanding its presence in diabetes care and offering a new treatment option for type 2 diabetes.